Uglavnom mislim na negativne posledice i procenat uspesnosti.
Ovde ocna kuca Sveti Vid radi punom parom sa ovim laserom tu nazovimo operaciju, pa me interesuje da li iko ima iskustva sa njima? Koliko sam ja shvatio njih, to je kao za 1 min gotovo, nema secenja i tih fora kao sto se radi u Rusiji, sve ragulise laser...
Koliko sam ja ranije gledao na netu, Excimer Laser nije bio odobren od strane U.S. Food and Drug Administration (FDA), ne znam sta je sada odluceno...
evo malo o odnosima sa FDA i neki opsti podaci:
---------------
There are risks involved with laser vision correction as there are with any surgical procedure. Some risks are loss of vision, visual side effects such as hazy vision, under/overcorrection. The use of an excimer laser has not been approved by the U.S. Food and Drug Administration (FDA) for use in LASIK. Rather, LASIK combines two already approved procedures: Automated Lamellar Keratoplasty (ALK) and Photorefractive Keratectomy (PRK).
© 2003 Massachusetts Eye and Ear Infirmary
---------------
LASIK has been performed internationally for approximately 10 years. It was first performed in U.S. clinical trials in 1991. It is important to note that the major components of the procedure have a long history. Ophthalmologists have been reshaping the cornea for over 50 years, creating a protective layer of tissue for over 35 years, and using the excimer laser since the 1980s.
In 1996, the FDA acted on the data submitted and approved the laser for treatment of low myopia up to -6.00 diopters. In 1997, the FDA approved the laser for treatment of astigmatism up to -4.00 diopters. There are currently three major manufacturers of the excimer laser equipment: Summit Technology, Visx and Nidek.
Oct. 21, 1999 - Summit Technology, Inc. announced that the U.S. Food and Drug Administration (FDA) granted approval for the Company's Apex Plus Excimer Laser Workstation for the LASIK treatment of myopia with or without astigmatism. The approval is for the correction of myopia in the range of 0D to -14.0D with or without astigmatism in the range of -0.5D to -5.0D. This approval gives Summit the widest range of treatments for nearsightedness and astigmatism in the industry.
Nov. 19, 1999 - VISX, INCORPORATED (Nasdaq:VISX) announced today that the U.S. Food and Drug Administration (FDA) has approved the use of its VISX STAR S2 Excimer Laser System(TM) as safe and effective for the treatment of up to 14 diopters of myopia, or nearsightedness, with up to 5 diopters of astigmatism.
September 30, 1999 - Nidek, Inc. announced the FDA had granted PMA supplement approval for the Company's EC-5000 Excimer Laser System for the treatment of Photorefractive Keratectomy for moderate myopia with astigmatism.
The new approval will allow treatment for the reduction or elimination of moderate myopia (nearsightedness) with astigmatism (uneven curvature of the cornea). The approval will allow correction of myopia ranging in severity from -1.00 to -8.00 diopters (D), with refractive astigmatism from -0.50 to -4.00 D cylinder by manifest refraction.
March 2000 - The LADARVision excimer laser, manufactured by Autonomous Technologies, Inc. and recently approved by the FDA, is a self aiming, small spot laser system for the correction of nearsightedness, farsightedness, and astigmatism. We are pleased to offer this next generation laser technology to our patients.
© 2000 LaserSurgeryForEyes.com
---------------
a dva oka ko strijele sijevnuse u hajduka
vojvode se uplasise od izgleda vuka gorskog..."